[1] Wang X,Lin SX,Tao J,et al.Study of liver cirrhosis over ten consecutive years in southern China. World J Gastroenterol,2014,20(37):13546-13555. [2] 程丹,邵志林,吴亮,等. 乙型肝炎肝硬化和肝癌患者血清铁蛋白检测的意义. 实用肝脏病杂志,2016,19(6):736-737. [3] Angulo P,Kleiner DE,Damlarsen S,et al.Liver fibrosis,but no other histologic features,is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology,2015,149(2):389-397,e10. [4] Qi X,Li H,Jiang C,et al.Serum liver fibrosis markers for predicting the presence of gastroesophageal varices in liver cirrhosis:a retrospective cross-sectional study. Gastroenterol Res Prac,2015,2015(3):1-6. [5] Reininghaus EZ,Lackner N,Birner A,et al.Extracellular matrix proteins matrix metallopeptidase 9(MMP9) and soluble intercellular adhesion molecule 1(sICAM-1) and correlations with clinical staging in euthymic bipolar disorder. Bipolar Disord,2016,18(2):155. [6] Gudowska M,Gruszewska E,Panasiuk A,et al.Hyaluronic acid concentration in liver diseases. Clin Exp Med,2016,16(4):523-528. [7] 连佳,韩涛,向慧玲,等. 恩替卡韦与阿德福韦酯单药治疗慢性乙型肝炎相关性肝病患者240周的随机对照研究. 中华肝脏病杂志,2015,23(10):733-737. [8] Hanai T,Shiraki M,Nishimura K,et al.Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition,2015,31(1):193-199. [9] Abbas M,Abbas Z.Serum cholinesterase:A predictive biomarker of hepatic reserves in chronic hepatitis D. World J Hepatol,2017,9(22):967-972. [10] Cheng BN,Jin YL,Chen BQ,et al.Serum cholinesterase:a potential assistant biomarker for hand,foot,and mouth disease caused by enterovirus 71 infection. Infect Dis Poverty,2016,5(1):27. [11] Ramachandran J,Sajith KG,Priya S,et al.Serum cholinesterase is an excellent biomarker of liver cirrhosis. Trop Gastroenterol,2014,35(1):15. [12] George TR,Ju MM,Heon KJ,et al.Effectiveness of losartan-loaded hyaluronic acid (ha) micelles for the reduction of advanced hepatic fibrosis in c3h/hen mice model. PLoS One,2015,10(12):e0145512. [13] Yang JA,Kong WH,Sung DK,et al.Hyaluronic acid-tumor nec-rosis factor-related apoptosis-inducing ligand conjugate for targeted treatment of liver fibrosis. Acta Biomater,2015,12(1):174. [14] 童芳芳. 肝硬化并发自发性细菌性腹膜炎患者血清与腹水TNF-α、IL-6和IL-8水平差异比较. 实用肝脏病杂志, 2015,18(2):191-192. [15] Gheorghe L,Rugin S,Dumitru IM,et al.HLA class Ⅱ alleles in Romanian patients with chronic hepatitis C. Germs,2015,5(2):44-49. [16] Shim HJ,Lee R,Shin MH,et al.Association between abo genotype and risk of hepatocellular carcinoma in Koreans. Asian Pac J Cancer Prev,2015,16(7):2771-2775. [17] Casrouge A,Decalf J,Ahloulay M,et al.Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest,2011,121(1):308-317. [18] Ingiliz P,Mayr C,Obermeier M,et al.Persisting hepatitis e virus infection leading to liver cirrhosis despite recovery of the immune system in an HIV-infected patient. Clin Res Hepatol Gastroenterol,2016,40(3):e23-e25. [19] Yadav S,Goel A,Saraswat V,et al.Evaluation of cognitivity,proinflammatory cytokines,and brain MRI in minimal hepatic encephalopathy induced by cirrhosis and ehpvo. J Gastroenterol Hepatol,2016,31(12):1986. [20] Angulo P,Kleiner DE,Damlarsen S,et al. Liver fibrosis,but no other histologic features,is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology,2015,149(2):389-397.e10. |